JP2018537968A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018537968A5 JP2018537968A5 JP2018522020A JP2018522020A JP2018537968A5 JP 2018537968 A5 JP2018537968 A5 JP 2018537968A5 JP 2018522020 A JP2018522020 A JP 2018522020A JP 2018522020 A JP2018522020 A JP 2018522020A JP 2018537968 A5 JP2018537968 A5 JP 2018537968A5
- Authority
- JP
- Japan
- Prior art keywords
- human
- light chain
- antibody
- rabbit
- immunoglobulin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 16
- 230000009261 transgenic effect Effects 0.000 claims description 16
- 108060003951 Immunoglobulin Proteins 0.000 claims description 15
- 102000018358 immunoglobulin Human genes 0.000 claims description 15
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 8
- 108091026890 Coding region Proteins 0.000 claims description 6
- 108700019146 Transgenes Proteins 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 239000000427 antigen Substances 0.000 claims description 3
- 108091007433 antigens Proteins 0.000 claims description 3
- 102000036639 antigens Human genes 0.000 claims description 3
- 230000035772 mutation Effects 0.000 claims description 3
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 claims description 2
- 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 claims description 2
- 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 claims description 2
- 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 claims description 2
- 102000013463 Immunoglobulin Light Chains Human genes 0.000 claims description 2
- 108010065825 Immunoglobulin Light Chains Proteins 0.000 claims description 2
- 101150117115 V gene Proteins 0.000 claims description 2
- 210000003719 b-lymphocyte Anatomy 0.000 claims description 2
- 239000012634 fragment Substances 0.000 claims description 2
- 230000004777 loss-of-function mutation Effects 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15192002.2 | 2015-10-29 | ||
| EP15192002.2A EP3184547A1 (en) | 2015-10-29 | 2015-10-29 | Anti-tpbg antibodies and methods of use |
| EP16162580.1 | 2016-03-29 | ||
| EP16162580 | 2016-03-29 | ||
| PCT/EP2016/075882 WO2017072208A1 (en) | 2015-10-29 | 2016-10-27 | Transgenic rabbit with common light chain |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018537968A JP2018537968A (ja) | 2018-12-27 |
| JP2018537968A5 true JP2018537968A5 (https=) | 2019-11-21 |
| JP7085992B2 JP7085992B2 (ja) | 2022-06-17 |
Family
ID=57233408
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018522020A Active JP7085992B2 (ja) | 2015-10-29 | 2016-10-27 | 共通軽鎖を有するトランスジェニックウサギ |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230332175A1 (https=) |
| EP (1) | EP3367786A1 (https=) |
| JP (1) | JP7085992B2 (https=) |
| CN (3) | CN108347906A (https=) |
| HK (1) | HK1258306A1 (https=) |
| SG (2) | SG11201802698XA (https=) |
| WO (1) | WO2017072208A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202008399QA (en) | 2018-03-12 | 2020-09-29 | Genmab As | Antibodies |
| US12467062B2 (en) | 2018-12-21 | 2025-11-11 | Compass Therapeutics Llc | Transgenic mouse expressing common human light chain |
| JP2023529846A (ja) * | 2020-06-02 | 2023-07-12 | バイオサイトジェン ファーマシューティカルズ （ベイジン） カンパニー リミテッド | 共通軽鎖免疫グロブリン遺伝子座を有する遺伝子改変非ヒト動物 |
| US20240067728A1 (en) * | 2020-11-06 | 2024-02-29 | Bio-Thera Solutions, Ltd. | Bispecific antibody and use thereof |
| CN115702931A (zh) * | 2021-08-06 | 2023-02-17 | 百奥泰生物制药股份有限公司 | 抗pd-l1/cd47双特异抗体在治疗疾病中的应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE299938T1 (de) * | 1997-05-02 | 2005-08-15 | Genentech Inc | Ein verfahren zur herstellung multispezifischer antikörper die heteromultimere und gemeinsame komponenten besitzen |
| CA2362098C (en) * | 1999-02-05 | 2011-10-11 | Jens-Ulrich Bulow | Human polyclonal antibodies from genetically engineered animals |
| EA013564B1 (ru) * | 2000-08-03 | 2010-06-30 | Терапеутик Хьюман Поликлоналз Инк. | Гуманизированный иммуноглобулин и содержащая его фармацевтическая композиция |
| ES2473596T3 (es) * | 2003-07-15 | 2014-07-07 | Therapeutic Human Polyclonals, Inc. | Loci de inmunoglobulina humanizada |
| US20080184380A1 (en) * | 2004-10-22 | 2008-07-31 | Therapeutic Human Polyclonals Inc. | Suppression of Endogenous Immunoglobulin Expression in Non-Human Transgenic Animals |
| CN103710371B (zh) | 2005-08-03 | 2017-03-01 | 人类多克隆治疗股份有限公司 | 表达人源化免疫球蛋白的转基因动物中b细胞凋亡的抑制 |
| PE20081216A1 (es) * | 2006-09-01 | 2008-09-04 | Therapeutic Human Polyclonals Inc | Expresion mejorada de la inmunoglobulina humana o humanizada en animales transgenicos no humanos |
| WO2009082624A2 (en) * | 2007-12-10 | 2009-07-02 | Zymogenetics, Inc. | Antagonists of il-17a, il-17f, and il-23 and methods of using the same |
| WO2009134805A2 (en) | 2008-04-28 | 2009-11-05 | Kalobios Pharmaceuticals, Inc. | Antibodies to granulocyte-macrophage colony-stimulating factor |
| JP2011526792A (ja) | 2008-07-02 | 2011-10-20 | エマージェント プロダクト デベロップメント シアトル， エルエルシー | ＴＮＦ−αアンタゴニスト多重標的結合性タンパク質 |
| PL3211005T3 (pl) | 2008-07-08 | 2021-11-29 | Geneuro Sa | Terapeutyczne zastosowanie specyficznego liganda w chorobach związanych z MSRV |
| JP2012502649A (ja) * | 2008-09-19 | 2012-02-02 | メディミューン，エルエルシー | Ｃｄ１０５を対象とする標的結合剤およびその使用 |
| US20130045492A1 (en) * | 2010-02-08 | 2013-02-21 | Regeneron Pharmaceuticals, Inc. | Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain |
| AU2011342799B2 (en) * | 2010-12-15 | 2016-06-09 | Wyeth Llc | Anti-Notch1 antibodies |
| US9248181B2 (en) | 2012-04-20 | 2016-02-02 | Merus B.V. | Methods and means for the production of Ig-like molecules |
| US20150203591A1 (en) * | 2012-08-02 | 2015-07-23 | Regeneron Pharmaceuticals, Inc. | Mutivalent antigen-binding proteins |
| HUE042040T2 (hu) * | 2012-09-27 | 2019-06-28 | Merus Nv | Bispecifikus IGG antitestek mint T-sejt kapcsolók |
| CA2916259C (en) * | 2013-06-28 | 2024-02-20 | Amgen Inc. | Methods for treating homozygous familial hypercholesterolemia |
| SG10201804945WA (en) | 2013-12-12 | 2018-07-30 | Shanghai hengrui pharmaceutical co ltd | Pd-1 antibody, antigen-binding fragment thereof, and medical application thereof |
| JP6771385B2 (ja) | 2014-02-28 | 2020-10-21 | メルス ナムローゼ フェンノートシャップ | 二重特異性抗体および医薬組成物 |
| EP4050026A1 (en) * | 2014-04-01 | 2022-08-31 | Adimab, LLC | Method of obtaining or identifying one or more common light chains for use in preparing a multispecific antibody |
-
2016
- 2016-10-27 SG SG11201802698XA patent/SG11201802698XA/en unknown
- 2016-10-27 CN CN201680063211.7A patent/CN108347906A/zh active Pending
- 2016-10-27 HK HK19100672.4A patent/HK1258306A1/zh unknown
- 2016-10-27 SG SG10202006332PA patent/SG10202006332PA/en unknown
- 2016-10-27 WO PCT/EP2016/075882 patent/WO2017072208A1/en not_active Ceased
- 2016-10-27 JP JP2018522020A patent/JP7085992B2/ja active Active
- 2016-10-27 CN CN202111174951.7A patent/CN113862300A/zh active Pending
- 2016-10-27 EP EP16790926.6A patent/EP3367786A1/en active Pending
- 2016-10-27 CN CN202111178978.3A patent/CN113897371A/zh active Pending
-
2022
- 2022-11-02 US US18/052,113 patent/US20230332175A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018537968A5 (https=) | ||
| JP2020536532A5 (https=) | ||
| JP2018138047A5 (https=) | ||
| JP2020514277A5 (https=) | ||
| JP2017504578A5 (https=) | ||
| JP2018046872A5 (https=) | ||
| JP2017052784A5 (https=) | ||
| JP2017114866A5 (https=) | ||
| JP2016512034A5 (https=) | ||
| JP2013538057A5 (https=) | ||
| JP2011036254A5 (https=) | ||
| WO2016207304A8 (en) | Monoclonal anti-il-1racp antibodies | |
| JP2011182801A5 (https=) | ||
| JP2018517431A5 (https=) | ||
| JP2017504577A5 (https=) | ||
| JP2010538608A5 (https=) | ||
| JP2014518615A5 (https=) | ||
| JP2014524243A5 (https=) | ||
| JP2020517287A5 (https=) | ||
| JP2018121657A5 (https=) | ||
| RU2019121086A (ru) | Иммунотерапия с применением антител, связывающих лиганд 1 белка программируемой смерти клеток (PD-L1) | |
| JP2012525829A5 (https=) | ||
| JP2009539348A5 (https=) | ||
| JP2018530331A5 (https=) | ||
| JP2020524510A5 (https=) |